Maternal Vitamin D, ADHD and Autism Risk: What the “9% Finding” Really Means

Could a mother’s vitamin D level during pregnancy influence her child’s later risk of ADHD or autism?

A large new analysis suggests that it might.

Researchers reviewed 15 studies involving 96,380 children and found that higher maternal vitamin D levels during pregnancy were associated with lower rates of both autism spectrum disorder and attention-deficit/hyperactivity disorder in offspring. The results also suggested that children exposed to higher vitamin D levels before birth tended to show fewer related behavioral symptoms—even when they did not meet the criteria for a formal diagnosis.

The most attention-grabbing result was what might be called the “9% finding”: for every 10 nanomoles per liter increase in maternal blood vitamin D, the relative risk of autism in offspring was approximately 9% lower.

That finding is intriguing. But it does not mean that taking a vitamin D pill during pregnancy has been proved to prevent autism or ADHD. The study identified an association, not a cause-and-effect relationship.

Here is what the research actually found—and what it may mean for prenatal brain health.

A Closer Look at the New Research

The systematic review and dose-response meta-analysis was published in June 2026 in European Child & Adolescent Psychiatry. Researchers examined studies measuring maternal or perinatal levels of 25-hydroxyvitamin D, commonly written as 25(OH)D, the primary blood marker used to evaluate vitamin D status.

The analysis included:

• Eight studies involving autism diagnoses or symptoms
• Five studies involving ADHD diagnoses or symptoms
• Two studies examining both conditions
• A combined population of 96,380 children from birth through age 17

Vitamin D was measured at different points across the studies, including the first or second trimester and, in several studies, at birth through cord blood or newborn blood samples.

When the researchers compared higher maternal vitamin D levels with lower levels, they found:

• A 9% lower relative risk of autism, with a relative risk of 0.91
• A 10% lower relative risk of ADHD, with a relative risk of 0.90

These percentages describe differences in relative risk, not absolute risk. They also come from comparisons across groups rather than from a clinical trial assigning women to different vitamin D treatments.

The “9% Finding” Applies to Autism Risk

The strongest dose-response result involved autism.

Across the available exposure range, the researchers found that autism risk decreased in a roughly linear pattern as maternal vitamin D levels increased. For each 10 nmol/L increase in maternal serum vitamin D, the relative risk of autism was approximately 9% lower.

A linear association means that the researchers did not identify a clear threshold at which the relationship suddenly appeared or disappeared within the range studied.

However, this should not be interpreted to mean that continually raising vitamin D levels will produce continually greater protection. Observational data cannot establish the ideal blood level for every pregnant woman, and excessive vitamin D can be harmful.

Experts often recommend blood levels between 40-60 ng/ml for optimization - avoiding deficiency, undernutrition, and excessive doses. Individuals will vary in how much they need to take to achieve the optimal dose range. Talk with your own doctor after they test your vitamin D blood level and monitor it over time.

It is also important not to transfer the 9% dose-response number directly to ADHD. For ADHD, the researchers found a roughly 10% lower risk when comparing higher with lower vitamin D status, but there were too few studies to establish the same precise dose-response relationship. The ADHD studies also varied considerably in their populations, methods and diagnostic criteria.

Why Vitamin D Matters to the Developing Brain

Vitamin D is best known for supporting calcium absorption and bone health. Biologically, however, it behaves more like a hormone than a conventional vitamin and has effects throughout the body, including the nervous and immune systems.

Vitamin D receptors are present in brain tissue, and experimental research suggests that vitamin D may participate in several processes involved in fetal brain development.

Neuronal growth and differentiation

During prenatal development, immature cells must multiply, migrate to the correct locations and mature into specialized neurons and support cells. Vitamin D appears to influence genes involved in neuronal proliferation and differentiation.

Neurotransmitter function

Vitamin D may help regulate systems involving dopamine, serotonin and gamma-aminobutyric acid, or GABA. These neurotransmitters contribute to attention, motivation, mood, impulse control and social behavior.

Immune and inflammatory regulation

Maternal inflammation can affect the environment in which the fetal brain develops. Vitamin D helps regulate immune activity and may influence levels of inflammatory signaling molecules.

Antioxidant and neuroprotective activity

Developing brain tissue is especially vulnerable to oxidative stress. Vitamin D may support antioxidant defenses and other mechanisms that protect developing neurons.

These biological effects make the association plausible, but biological plausibility is not the same as clinical proof. Vitamin D is only one of many nutritional, genetic, developmental and environmental factors that may influence neurodevelopment.

Vitamin D May Influence Traits as Well as Diagnoses

Another interesting aspect of the analysis was its examination of symptoms along a continuum.

Autism and ADHD are diagnosed when a person’s pattern of traits reaches established clinical criteria and causes meaningful impairment. However, attention, impulsivity, social responsiveness and repetitive behavior vary throughout the population.

The studies included standardized behavioral measures such as the Social Responsiveness Scale, the Strengths and Difficulties Questionnaire and the Child Behavior Checklist.

Higher maternal vitamin D levels were generally associated with fewer autism-related and ADHD-related symptoms. This suggests that prenatal vitamin D status might be associated not only with whether a child crosses a diagnostic threshold, but also with the overall intensity of certain traits.

The symptom findings for ADHD were less certain because they came from a limited number of studies and some estimates were statistically imprecise.

It would therefore be premature to claim that vitamin D supplementation improves attention or social development in every child. The results instead provide a reason for further research.

Association Does Not Prove Prevention

This distinction is especially important.

Most of the evidence included in the meta-analysis came from observational studies. Researchers measured vitamin D levels and then looked for differences in later outcomes. They did not randomly assign women to maintain different vitamin D levels.

Women with higher vitamin D may differ from women with lower levels in many other ways, including:

• Diet quality
• Supplement use
• Outdoor activity
• Sun exposure
• Body weight
• Socioeconomic conditions
• Access to prenatal care
• Smoking or alcohol exposure
• Chronic health conditions
• Genetic factors

Researchers attempt to adjust statistically for these variables, but they cannot always eliminate every source of confounding.

Clinical trials also complicate the picture. In one randomized trial, high-dose vitamin D supplementation during pregnancy did not reduce autism or ADHD diagnoses, although women who already had higher vitamin D levels before the intervention had children with lower rates of these outcomes.

This could mean that vitamin D is a marker of broader maternal health, that timing matters, that correcting severe deficiency is more relevant than giving high doses to everyone, or that other biological factors influence how vitamin D is used.

Should Pregnant Women Have Their Vitamin D Tested?

The new analysis supports greater attention to vitamin D deficiency during pregnancy, but it does not establish universal testing as a standard preventive measure for autism or ADHD.

The National Institutes of Health lists the recommended dietary allowance during pregnancy as 15 micrograms, or 600 international units, per day. The tolerable upper intake level for pregnant adults is 100 micrograms, or 4,000 IU, per day from all sources unless a clinician recommends and supervises a different amount.

The American College of Obstetricians and Gynecologists has stated that routine vitamin D screening for every pregnant woman is not supported by sufficient evidence. When deficiency is identified, however, ACOG notes that daily supplementation of 1,000 to 2,000 IU is generally considered safe.

Individual needs can vary based on factors such as skin pigmentation, sun exposure, diet, obesity, malabsorption disorders, kidney or liver disease and certain medications.

Pregnant women should therefore discuss testing and supplementation with their obstetrician or other qualified healthcare professional rather than beginning high-dose vitamin D on their own.

What This Study Does—and Does Not—Tell Us

The study provides several important insights:

It strengthens the evidence for an association.
Across multiple studies, lower maternal vitamin D status was associated with higher rates of autism, ADHD or related symptoms.

It identifies a notable dose-response pattern for autism.
Autism risk was approximately 9% lower for each 10 nmol/L increase in maternal vitamin D across the studied range.

It supports biological research on vitamin D and brain development.
Vitamin D participates in neuronal development, neurotransmitter function, immune regulation and antioxidant protection.

At the same time:

It does not prove that deficiency causes autism or ADHD.

It does not prove that supplementation prevents either condition.

It does not establish an ideal prenatal blood level for neurodevelopmental protection.

It does not justify unsupervised high-dose supplementation.

The Bottom Line

Vitamin D appears to be more than a bone-health nutrient during pregnancy. It participates in biological systems that help guide fetal brain development, regulate inflammation and support neuronal function.

The latest evidence suggests that higher maternal vitamin D status is associated with lower rates of autism and ADHD in offspring. The clearest numerical finding—a 9% reduction in relative autism risk for every 10 nmol/L increase—deserves attention, but it should not be presented as proof that a prenatal supplement can prevent autism.

For pregnant women, the practical message is not to chase unusually high vitamin D levels. It is to make sure that basic nutritional needs are being met, discuss personal deficiency risk with a healthcare professional and correct a documented deficiency appropriately.

Vitamin D may eventually become a more prominent part of prenatal neurodevelopmental care. For now, the evidence supports thoughtful assessment and adequate nutrition—not dramatic promises about prevention.

This article is for educational purposes and is not a substitute for individualized medical advice. Pregnant women should consult their healthcare professional before changing supplement doses.